Shirley S. Wang writes in the WSJ about impressive but small-sample-size research using intravenous immunoglobulin therapy to treat Alzheimer's disease.
Blog Editor
- Prof. Adam Kolber
Brooklyn Law School - My Publications
- For blog info, click below on "About"
Guest Bloggers
Former Guests
- Gavin Enck
- Katrina Sifferd
- David Gunkel
- Lisa Bortolotti
- Sasha Davenport
- Tommaso Bruni
- Syd Johnson
- Andrea Lavazza
- Christopher Ryan
- Marc Blitz
- Heidi Maibom
- Peter Reiner
- Daniel Goldberg
- Jody Madeira
- Christopher Buccafusco
- Kevin Jon Heller
- Emily Murphy
- Stacey Tovino
- Jeremy Blumenthal
- Caitlin Connors
Other Sites
- Ask Philosophers
- BoingBoing
- Concurring Opinions
- Conference Alerts
- CrimProf Blog
- Freakonomics Blog
- How Appealing
- Legal Scholarship Blog
- Legal Theory Blog
- Leiter Reports
- Leiter's Law School Reports
- Marginal Revolution
- PrawfsBlawg
- Prison Law Blog
- Sentencing Law and Policy
- The Right Coast
- Volokh Conspiracy
Search
Notices
- Copyright 2005-20012 by Adam Kolber
All rights reserved.
« "Review: Thinking, Fast and Slow by Daniel Kahneman" | Main | "Neuroscience Meets Cryptography" with Manchurian Candidate Undertones »
The comments to this entry are closed.
Comments